Bendamustine
CAS:97832-05-8
Purity: 95% HPLC
Molecular formula: C16H21Cl2N3O2.HCl
Molecular weight: 394.72
![]()

1. Bendamustine is a chemotherapy drug mainly used to treat various types of leukemia and lymphoma, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, lymphoblastic leukemia, etc.
2. The mechanism of action of Bendamustine includes DNA damage and apoptosis, thereby inhibiting the growth and spread of cancer cells.
3. Bendamustine is usually used as first-line treatment or relapse treatment, and can be used alone or in combination with other drugs, such as rituximab (rituximab) or other chemotherapy drugs.
![]()
Bendamustine can be administered by intravenous injection, usually every 2-4 weeks.



